President Barack Obama has signed into law two international patent treaties that could help U.S. pharma companies expand into foreign markets and save money when filing in multiple countries. Co-authored by Sens. Patrick Leahy (D-Vt.) and Chuck Grassley (R-Iowa), the law, called the Patent Law Treaties Implementation Act of 2012, allows U.S. companies to use a single filing for patent protection in all 45 countries that have signed onto the Geneva Act of the Hague Agreement Concerning International Registration of Industrial Design.
Washington Drug Letter